Announcements Trials
Browse Landscape

Phase

Phase 2 641Phase 1 254Phase 3 155Phase 1/2 129Phase 2/3 17Phase NA 11Phase EARLY_PHASE1 4Phase 4 3

Status

Completed 4Unknown 3Withdrawn 2Terminated 2Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 3CNS 1

Conditions

Pancreatic Neoplasms 2Pancreatic Adenocarcinoma 1Diffuse Intrinsic Pontine Glioma 1

Interventions

Magnetic Resonance Spectroscopy 23Metformin 14pembrolizumab 12Radiotherapy 12Biopsy 11Nivolumab 9Fluorouracil 9Cyclophosphamide 9Temozolomide 7Radiation 7Bevacizumab 7gallium 68 PSMA-11 6Sirolimus 6Rituximab 6Letrozole 6Etoposide 6Cisplatin 6Aspirin 6olaparib 5Surveys and Questionnaires 5Radiosurgery 5Oxaliplatin 5Irinotecan 5Indocyanine Green 5Granulocyte Colony-Stimulating Factor 5Fluorodeoxyglucose F18 5Dexamethasone 5aldesleukin 4Surgical Procedures, Operative 4Proflavine 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Completed × Gemcitabine × Clear all
NCT02992015 2025-03-07

Gemcitabine in Newly-Diagnosed Diffuse Intrinsic Pontine Glioma

University of Colorado, Denver

Phase EARLY_PHASE1 Completed
2 enrolled
CNS

Diffuse Intrinsic Pontine Glioma

NCT01821612 2025-01-13

Chemotherapy and Radiation Therapy Before Surgery Followed by Gemcitabine in Treating Patients with Pancreatic Cancer

Alliance for Clinical Trials in Oncology

Phase EARLY_PHASE1 Completed
23 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT02550327 2021-06-22

Gemcitabine, Nab-Paclitaxel, Cisplatin and Anakinra Treatment on Patients With Pancreatic Cancer

Baylor Research Institute

Phase EARLY_PHASE1 Completed
20 enrolled
Gastrointestinal

Pancreatic Adenocarcinoma

NCT01715142 2020-09-04

NEOPAX-001

Erasme University Hospital

Phase EARLY_PHASE1 Completed
23 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡